ResMed (RMD) EV/EBITDA US GAAP (year values) |
|||||||||
2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | ||||
EV/EBITDA | ? | 33.0 | 26.2 | 1.01 | 24.9 | 15.0 | |||
Changes by years, y/y, % | +1% | -100% | -96% | +2 372% | +2.3% |
ResMed. EV/EBITDA
ResMed. EV/EBITDA, changes, %
ResMed (RMD) EV/EBITDA US GAAP (quarter values) |
||||||||
2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
EV/EBITDA | ? | 17.6 | 21.3 | 18.6 | 0.64 | 19.9 | 15.0 | |
Changes by years, y/y, % | -36% | -18% | -28% | -98% | -23% | |||
Changes by quarters, q/q, % | -30% | +21% | -13% | -97% | +3 014% |